Multiplex Assay Kit for Amyloid Precursor Protein (APP) ,etc. by FLIA (Flow Luminescence Immunoassay)

AAA; ABeta; ABPP; AD1; APPI; CVAP; PN2; CTFgamma; Peptidase Nexin-II Alzheimer Disease; Peptidase Nexin-II; Amyloid Beta(A4)Precursor Protein

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Amyloid Precursor Protein (APP) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Amyloid Precursor Protein (APP) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Amyloid Precursor Protein (APP) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Amyloid Precursor Protein (APP) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 83-102 94
EDTA plasma(n=5) 95-102 98
heparin plasma(n=5) 96-105 99
sodium citrate plasma(n=5) 84-99 93

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Amyloid Precursor Protein (APP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Amyloid Precursor Protein (APP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Amyloid Precursor Protein (APP) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 81-104% 93-105% 78-88% 99-105%
EDTA plasma(n=5) 94-102% 89-97% 85-101% 99-105%
heparin plasma(n=5) 94-101% 94-105% 91-98% 95-102%
sodium citrate plasma(n=5) 98-105% 89-102% 85-97% 88-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:APP) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Neurochemistry International Bilobalide regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway ScienceDirect: S0197018611001641
Neuroscience Substitution of membrane cholesterol with β-sitosterol promotes nonamyloidogenic cleavage of endogenous amyloid precursor protein Pubmed: 23707801
OncoImmunology PROOF COVER SHEET
台湾农业研究 (台灣農業研究67 (4): 355-364) 香菇柄水萃物改善糖尿病降低阿茲海默氏症罹病風險初探
Neurotoxicology Involvement of hippocampal agmatine in β1-42 amyloid induced memory impairment, neuroinflammation and BDNF signaling disruption in mice Pubmed: 32522471
Metab Brain Dis Probiotics ameliorates LPS induced neuroinflammation injury on Aβ 1–42, APP, γ-β secretase and BDNF levels in maternal gut microbiota and fetal … Pubmed:35312928
Exp Gerontol The positive impact of 12 weeks of dance and balance training on the circulating amyloid precursor protein and serotonin concentration as well as physical and … Pubmed:35217193
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB020Hu02 Recombinant Amyloid Precursor Protein (APP) Positive Control; Immunogen; SDS-PAGE; WB.
RPB020Hu03 Recombinant Amyloid Precursor Protein (APP) Positive Control; Immunogen; SDS-PAGE; WB.
RPB020Hu01 Recombinant Amyloid Precursor Protein (APP) Positive Control; Immunogen; SDS-PAGE; WB.
PAB020Hu01 Polyclonal Antibody to Amyloid Precursor Protein (APP) WB; IHC; ICC; IP.
PAB020Hu02 Polyclonal Antibody to Amyloid Precursor Protein (APP) WB; IHC; ICC; IP.
PAB020Hu03 Polyclonal Antibody to Amyloid Precursor Protein (APP) WB; IHC; ICC; IP.
MAB020Hu22 Monoclonal Antibody to Amyloid Precursor Protein (APP) WB; IHC; ICC; IP.
MAB020Hu23 Monoclonal Antibody to Amyloid Precursor Protein (APP) WB; IHC; ICC; IP.
WEB020Hu Wide-range ELISA Kit for Amyloid Precursor Protein (APP) Enzyme-linked immunosorbent assay for Antigen Detection.
SEB020Hu ELISA Kit for Amyloid Precursor Protein (APP) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB020Hu CLIA Kit for Amyloid Precursor Protein (APP) Chemiluminescent immunoassay for Antigen Detection.
LMB020Hu Multiplex Assay Kit for Amyloid Precursor Protein (APP) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.